Ascend Announces Q124 Earnings
$142.4M Revs; est. $139.8M
$33M AEBITDA; est. $30M
$52M GP; est. $51.2M
$2.6M OI; est. $8.5M
36.5% GM; est. 36.6M
($ 18.2M) adjNI; est. ($13.4M)
“Looking ahead to the rest of the year, we are optimistic about our financial outlook. We project revenue growth between approximately 12% and 15%, and an adjusted EBITDA increase of approximately 17% to 22% compared to 2023.
Additionally, we are targeting cash from operations generation for the full year between $55 million and $65 million," Mark Cassebaum, Chief Financial Officer.
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.